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Immunologic mechanisms leading to the deposition of immune complexes in
glomeruli are the main causative factors in many renal diseases . Little is known,
however, about the molecular mechanisms responsible for the accumulation of
immune deposits (IDs)' in the glomerulus. To gain insights into this problem we
have been studying the formation of IDs in Heymann nephritis (HN), an
experimental model of human membranous nephropathy, which is known to be
caused by the interaction between an endogenous glomerular antigen and
circulating anti-brush border antibodies (1, 2) . Previously, we have identified
the pathogenic antigen as a large membrane glycoprotein, gp330 (3), and have
shown by immunoelectron microscopy that it resides in clathrin-coated pits
located both in the proximal tubule brush border and in the glomerular epithe-
lium (4-9) . These findings have subsequently been confirmed by others (10-18) .
Moreover, we presented evidence that when anti-gp330 IgG is injected into
normal rats producing so-called passive HN and their kidneys are examined 3 d
later, the injected IgG that binds to glomeruli is sometimes found in clathrin-
coated pits located at the base of the foot processesof the glomerular epithelium
(4-8) . Based on these findings we postulated (4-7) that (a) the coated pits on the
soles of the foot processes represent the sites where the circulating anti-gp330
IgG and the membrane-associated antigen, gp330, meet ; (b) the immune com-
plexes thus formed are subsequently shed into the lamina rara externa of the
GBM where theybecome the nidus of an ID ; and (c) the shed immune complexes
become stabilized in the lamina rara externa by crosslinking .
We here report results that fully confirm these postulates and allow us to
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reconstruct some ofthe early events that occur in the formation ofsubepithelial
IDs in passive HN.
Materials and Methods
Animals.
￿
Male Sprague-Dawley rats (200-250 g) were obtained from Charles River
Breeding Laboratories, Inc., Wilmington, MA, or from the Tierzuchtinstitut der Uni-
versitat Wien, Himberg, Austria.
Materials. Chloramine T, pepstatin A, antipain, leupeptin, benzamidine, DIFP,
DNAse (type II), diethylamine, Triton X-100, p-phenylenediamine, diaminobenzidine
hydrochloride (DAB, type II), BSA and poly-D,L-lysine hydrobromide were purchased
from Sigma Chemical Co., St. Louis, MO; CNBr-activated Sepharose CL-4B and Phar-
malytes (pH 3-10) were from Pharmacia Fine Chemicals, Piscataway, NJ; Iodogen was
from Pierce Chemical Co., Rockford, IL; sodium-deoxycholate (DOC), Aquacide II, and
Azocoll were from Calbiochem-Behring Corp., San Diego, CA; SDS and acrylamide were
from Bio-Rad Laboratories, Richmond, CA; 1251 was from Amersham Corp., Arlington
Heights, IL; CLSPA-collagenase was from Worthington Biochemical Corp. (Freehold,
NJ). Heparinase and cationized ferritin, pI 8.6-9.3, were from Miles Laboratories, Inc.
(Naperville, IL). F(ab')2 fragments of goat anti-rabbit IgG conjugated to FITC, and
FITC-conjugated rabbit anti-goat IgG were obtained from Cooper Biomedical, Inc.,
Malvern, PA; F(ab) fragments ofsheep anti-rabbit and sheep anti-mouse IgG conjugated
to horseradish peroxidase (HRP) were from Biosys, Compiegne, France; goat anti-rabbit
IgG coupled to 10 nm gold (GAR 10), goat anti-mouse IgG coupled to 5 nm gold (GAM
5), and protein A-gold (5 nm) were purchased from Janssen Life Sciences, Piscataway,
NJ. MEM with Eagle's salts was from Gibco Laboratories (Grand Island, NY).
Preparation of Polyclonal and Monoclonal Antigp330 IgG.
￿
Polyclonal anti-gp330 IgG
was obtained from a rabbit immunized with purified gp330 as described previously (4).
This IgG specifically recognizes gp330 and maltase (an antigenically related glycoprotein)
by immunoprecipitation (9). Its titer is >2,000 (at 10 mg IgG/ml) by indirect immunoflu-
orescence on cryostat sections of normal rat kidney. Mouse monoclonal anti-gp330 IgG
was obtained from clone D1 55F2. It recognizes only gp330 by immunoprecipitation (9).
Normal rabbit IgG was purified from sera of nonimmunized rabbits.
Iodination ofRabbit IgG.
￿
IgG was labeled with 1251 by the iodogen procedure (19) (sp
act, 250 X 106 cpm/mg). Nonimmune rabbit IgG was similarly labeled (sp act, 120 X 106
cpm/mg) as a control. The nonimmune IgG was depleted of anti-gp330 crossreactivity by
circulating it for 12 h over a column containing purified gp330 immobilized to Sepharose
4B by CNBr.
Induction of Passive HN
￿
20 rats were infused for 1 min intravenously via the jugular
or saphenous vein with 3-5 mg rabbit anti-gp330 IgG, and their kidneys were collected
as described below after 15 (4 rats) or 30 min (2), 1 (4) or 2 h (2), or 1 (2), 3 (4), or 8 d
(2), and they were processed for immunofluorescence and immunoelectron microscopy.
12 rats were similarly injected with a mixture of 2 mg of 1251-labeled rabbit anti-gp330
IgG and 3 mg nonradiolabeled anti-gp330 IgG suspended in 0 .5-0.7 ml PBS. The animals
were killed after 15 min (4 rats), 1 h (4), or 3 d (4), and their kidneys were collected and
used for isolation of glomeruli and GBMs. Seven additional rats were injected with 5 mg
1251-labeled nonimmune rabbit IgG, and their kidneys were collected after 15 min (2 rats),
I h (2), and 3 d (3).
Preparation and Processing of Tissue for Immunocytochemistry.
￿
Kidneys of rats injected
with anti-gp330 IgG and controls were perfused via the abdominal aorta with 25-30 ml
of MEM for 5 min at 20°C. The left renal artery was ligated, the left kidney was removed,
and tissue samples were frozen and stored in liquid N2 until used for immunofluorescence.
The right kidney was perfused with 15-20 ml of periodate-lysine-paraformaldehyde
fixative (PLP) (20) for 3 min. Small blocks were prepared from the cortex, fixed further
by immersion in PLP for 4-6 h at 20°C, after which they were cryoprotected in 10%
DMSO, and frozen in liquid N2-cooled isopentane until processed for immunoperoxidase
(4, 8, 9).KERJASCHKI ET AL.
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Immunofuorescence.
￿
Cryostat sections (4 gym) were incubated with FITC-goat anti-
rabbit F(ab')2 (to detect rabbit IgG) for 20 min, washed in PBS (3 X 15 min), and mounted
in glycerol, In the case of the 15-min group (Fig. 1 A), sections were also incubated with
FITC-rabbit anti-goat IgG (20 min) to enhance the fluorescent signal. Sections were
examined in a Photomicroscope III (Carl Zeiss, Inc., Thornwood, NY), equipped with
epifluorescence illumination.
Immunoperozidase.
￿
Cryostat sections (20 jm) prepared from PLP-fixed kidney samples
were incubated either in (a) sheep anti-rabbit Fab-HRP (diluted 1 :50) for detection of
bound rabbit IgG, or (b) in monoclonal anti-gp330 IgG (10 ug/ml) followed by sheep
anti-mouse Fab-HRP for detection of endogenous gp330. The sections were then fixed
in 1 .5% glutaraldehyde in 100 mM cacodylate buffer, incubated in DAB-medium (0.1%
DAB, 0.01% H202) for 1-3 min, postfixed in ferrocyanide-reduced OSO4, and embedded
in Epox as described (4, 9). Ultrathin sections were stained with alkaline lead citrate and
examined in a Philips 301 or a Zeiss 9S electron microscope.
Isolation of Glomeruli and GBMs.
￿
Kidneys of rats injected with ,21I-labeled IgG were
perfused with MEM for 2-3 min at 20°C and then removed and frozen in liquid N2.
Those obtained from all rats of a given time point were pooled, and the glomeruli were
isolated by sieving, yielding a fraction of >80% purity. A small aliquot was processed for
morphological studies, and another was saved and counted in a Biogamma Counter
(Beckman Instruments, Inc., Fullerton, CA). The remaining glomeruli of each experi-
mental group were mixed with those prepared from 8-10 normal (noninjected) rat
kidneys as a carrier.
GBMs were purified (21) by extracting isolated glomeruli with distilled water (1 h at
20°C), followed by digestion with 1 U/ml DNAse in unbuffered 1 mM CaC12 (30 min).
The suspension was then centrifuged (1 min at 10,000 g in a Microfuge), and the pellet
was resuspended (2 h) in 1 % DOC in Tris-buffered saline (TBS), pH 7.2, with 0 .1 % BSA,
containing protease inhibitors (1 mM DIFP, 5 mM pepstatin A, 5 mM antipain, 5 mM
leupeptin, 10 mM benzamidine, 1 mM iodoacetamide, and 5 mM EDTA). The superna-
tants obtained were saved and counted to determine the cpm released at each step in the
GBM purification procedure. The resultant pellet containing the GBMs was subsequently
washed (5X) in TBS with 0.1% BSA by repeated pelleting (30 s in a Microfuge) and
resuspension. The isolated GBMs were then either counted for bound radioactivity or
processed for immunolabeling.
Quanlitation of the Effects of Various Treatments on Release of Rabbit IgG Bound to the
GBM. Aliquots of unfixed GBMs isolated from the 3 d group were incubated in
suspension in Eppendorf vials in: (a) 1 or 2 M NaCl for 2 h at 20°C; (b) 0.1 U heparinase
in 0.1 M acetate buffer, pH 6.0, containing protease inhibitors (1 mM pepstatin, 1 mM
antipain, and 10 mM benzamidine) for 12 h at 37'C; (c) 0.01 mg collagenase in 200 mM
NaCI, 5 mM CaCl2, 100 mM Tris-HCI, pH 7 .5, containing the same protease inhibitors
as in a for 6 and 12 h at 37 °C; (d) 100 mM diethylamine in distilled water (pH >11); or
(e) 1 M acetic acid (pH <3 .0) for 30 min at 20 °C. The GBMs were pelleted by
centrifugation (5 min in a Microfuge) and the radioactivity of the supernatant and pellet
was determined.
Double Immunolabeling ofIsolated GBMs.
￿
Isolated GBMs were prepared for immuno-
electron microscopy from rats given '25I-labeled anti-gp330 or nonimmune IgG by two
methods: Freshly prepared, unfixed GBMs were suspended in PBS mixed 1 :1 with 3%
agarose in PBS, and cast into a thin film (22). Small strips (2 X 3 mm) were cut from the
agarose films and incubated 2 h at 20°C with 5 nm gold-protein A conjugate diluted 1 :5
in PBS containing 1% OVA to localize rabbit IgG. After washing (3 X 2 h) in PBS, they
were then processed by the immunoperoxidase procedure for localization of endogenous
gp330 as described above.
Alternatively, GBMs were suspended in PBS and 50-,l aliquots were dropped onto
glass slides precoated with poly-L-lysine. After incubation for 2 h at 4° C, the unbound
material was removed by rinsing with PBS, and the slides were immersed in PLP-fixative
for 30 min. After washing (3 X 20 min) in PBS with 1% OVA, the immobilized GBMs
were incubated sequentially in (a) 25 mM glycine in PBS for 15 min (to quench free11 2
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aldehyde groups; (b) 10 nm gold-goat anti-rabbit IgG in PBS containing 1 % OVA for 6
hat 4°C (to detect the injected rabbit IgG); (c) monoclonal anti-gp330 IgG (10-15,ug/ml)
in PBS for 6 h at 4°C; and (d) 5 nm gold-goat anti-mouse IgG for 6 h (to detect
endogenous gp330). After washing (4 h) in PBS, the samples were fixed in 2.5%
glutaraldehyde (1 h), 100 mM cacodylate buffer, pH 7.2, postfixed in 1% OS04 (1 h) in
the same buffer, and embedded in Epox.
Controls consisted of incubations in which the monoclonal anti-gp330 IgG was omitted,
or the specimens were preincubated in goat anti-rabbit IgG (2 mg/ml).
Quantitation ofIDs in Tissue Sections and in Isolated GBMs.
￿
Electron micrographs were
taken (X25,000) of two to four glomeruli from each kidney in specimens reacted for
rabbit IgG by immunoperoxidase. All the capillary loops of a given glomerulus were
photographed, and the following parameters were determined for each experimental
group: (a) the number of IDs/100 Am of GBM, (b) the number of IDs located under the
foot processes vs. those located beneath the slit diaphragms, and (c) the number of foot
processes per micrometer GBM.
The number of IDs/100 Am GBM was also determined in GBMs isolated from each
experimental group and processed for immunogold labeling. In addition, the number of
10-nm (indicating rabbit IgG) and 5-nm (indicating gp330) gold particles present in the
IDs were counted and their ratio was calculated.
Reconstruction ofIDsfrom Serial Sections-Ribbons of 60-80-nm sections prepared from
specimens reacted by immunoperoxidase for rabbit IgG were collected on carbon-form-
var-coated grids, and identical areas of serial section were photographed (X25,000). The
micrographs were then overlayed with transparent paper, and the contours o£ individual
IDs were traced. The three-dimensional shape of 45 IDs was reconstructed by superim-
posing the tracings of each ID, and the relationship of individual IDs to coated pits and
slit diaphragms was determined.
Immunoprecipitation with IgG Eluted from IDs.
￿
Glomeruli isolated from rats injected
with 10 mg unlabeled rabbit-anti gp330 IgG 3 d earlier were extracted with 20 mM
citrate buffer, pH 3 .2, at 37° for 30 min, followed by extraction with the same buffer,
pH 2.8, as described previously (3, 23). The eluted IgGs were used for immunoprecipi-
tations from '21I-labeled microvillar fractions solubilized in RIPA-buffer (3).
Isoelectric Focusing ofIgG.
￿
GBMs were isolated from a control rat and from two rats 1
h and 3 d after injection with '21I-labeled anti-gp330 IgG; they were then extracted with
100 mM diethylamine (pH >11) for 15 min at 20°C to release the bound IgG (24). The
supernatants containing the extracted IgG were neutralized with 1 M HCI, dialyzed
against TBS, and incubated with 200 Al protein A-Sepharose 4B (I h at 4 ° C). After
washing (10 ml TBS), the IgG bound to the protein A beads was released with 1 M acetic
acid, containing 1 mg/ml of nonradioactive rabbit IgG as a carrier. The fractions were
neutralized with 1 M NaOH, lyophilized, and redissolved in 20 Al distilled water. The
isoelectric points of the eluted anti-gp330 IgG and of the radioiodinated and nonradioio-
dinated anti-gp330 IgG used for injection were determined by isoelectric focussing in a
Bio-Rad Laboratories flatbed electrophoresis apparatus with Pharmalytes establishing a
pH gradient of 2 .9-9.5. Cationized ferritin (pI 8.6-9.5) and BSA (pI 4.5) were used as
standards. One lane of the agarose gel was cut into 0.5-cm strips, which were incubated
in I ml distilled water (I h) to extract the ampholytes, and the pH of the extracts was
measured. The agarose gels were fixed and stained in 25% methanol-7% acetic acid with
0.1 % Coomassie blue, dried, and exposed for autoradiography.
Results
IDs Originate in Coated Pits and Become Associated with Slit Diaphragms.
￿
The
formation of glomerular IDs was studied by immunofluorescence and by immu-
noelectron microscopy in rats killed at 15 min to 8 d after the injection of rabbit
anti-gp330 IgG. As early as 15 min after the injection, a very fine granular
pattern of staining for rabbit IgG was detected by immunofluorescence along
the GBM (Fig. 1 A). At 1 h and 3 d the size of the IDs and their staining intensityKERJASCHKI ET AL.
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FIGURE 1 .
￿
Detection of rabbit IgG in rat glomeruli by direct immunofluorescence at 15 min
(A), 1 h (B), and 3 d (C) after injection of 5 mg "'I-labeled, rabbit anti-gp330 IgG. At 15 min,
rabbit IgG is distributed in a faint granular pattern along the GBM (A). The sizes of the
granular deposits become larger with time (B and C). x650.
were increased (Fig . 1, B and C) . There was no staining of any structure other
than the GBM . These findings are in agreement with previous studies (1, 2), in
which granular deposits of anti-FxIA-IgG were observed as early as 5-10 min
after injection .
When rabbit IgG was localized by immunoperoxidase at the electron micro-
scope level, at 15 min (Figs . 2A and 3, A-C) or I h (Fig . 3, D and E) after
antibody injection the bound IgG was found largely or exclusively in coated pits
at the base of the epithelial foot processes . It is precisely in this location that the
antigen, gp330, is known to reside (4-10, 12, 15) . Anti-
detected along the remaining (noncoated) areas of the epitheli
at the base of the foot processes or in any other location .
After 1 d, some of the IgG was still seen in basally located coated pits which
were enlarged and were filled with reaction product (Fig . 3, Fand G), but as the
IDS enlarged in size they were found with increasing frequency under the slit
diaphragms . As before, only some of the coated pits contained IDs (Fig . 3 F) . At
3 d the IDs were larger and they were found more often under the slitdiaphragms
(Fig . 4) . At 8 d the relationship of IDs to coated pits was seldom evident in
individual sections, and most o£ the large IDs were found under the slit dia-
phragms or beneath noncoated regions of the epithelial cell membrane at the
base of the foot processes (Figs . 2B and 3H) .
The number of foot processes per 100 um GBM remained fairly constant up
to 3 d (280 at 15 min ; 230 at 3 d), but was slightly decreased at 8 d (190/Am
GBM) . The average size of the foot processes thus increased from 0.36 '.m (15
min) to 0 .53 um (8 d) .
No DAB-reaction product was seen in the kidneys of rats injected with normal
rabbit IgG .
Serial Sectioning Reveals
dimensional shapes and relation
from serial sections such as those
idase preparations of rats given ra
results demonstrated that the size and shape of the IDs varied considerably ; they
ranged from small globules to large complicated structures with openings
13
Associated mine Coated Pits .
￿
The three-
of 45 different IDs were reconstructed
Fig . 4 prepared from immunoperox-
i-gp330 IgG 3 d before killing . The114
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irect immunoperoxidase localization ofrabbit IVA in glameruli of rats in
it and,330 IVA and fixed at 15 min (A) or 8 d {B} after injection.
min, three small IDs are seen in the lamina rara externs (arrows) at the base of the epithelial
foot processes of this capillary {cap}, At 8 d the deposits are larger, more numerous,and are
oftenfound in association with slit diaphragms (arrows). Note the absence of reaction product
on the endothelial cell surfaces and in the lamina rara interns . Cryostat sections were incubated
in sheep anti-rabbit Fob-HRP conjugate followed by theDAB reaction . x 18,000 .located near a slit diaphragm
pically associated with coated pits.
I d (F and G), the IDsare increased in size, an
ms Ody as well as 0 coated pits . As at I h, some coated
F) . At 8 d (H), the IDs are still larger and are found i
the slit diaphragms (sd) and thenoncoated regions of the
30000 .
ional",
he deposits
l of rabbit
and under
contain
inFIGURE 4.
￿
Serial (not consecutive) sections through two IDs (A-C and 17-F} in glomeruli of
rats given rabbit anti-gp330 IgG 3 d before killing andprocessed as in Figs . 2and 3. Individual
foot processes are numbered to facilitate their identification . In both series, IDs are present
that seem to be located under the slit diaphragms (sd) in a given section . However, when
followed in serial sections, it is apparent that theseIDs are actually extensionsoflarger deposits
that at some level are in contact with a basally located coated pit (cp). x 30,000 .
through which the foot processes still contacted the GBM (Fig . 5).
d to be located under the slit diaphragms in indivi
ig. 4) it was obvious
sanalyzed made contact with a coated pitora larger clathrin-
coated area of the basal epithelial plasma membrane at some level .
The Number ofIDs Increases with Time.
￿
Counts of IDs in kidney sections (Table
1) indicate
ins f1i creases to ~90/I00jum
ed GBM.
￿
When GBMs isKERJASCHKI ET AL.
FIGURE 5. Three-dimensional shapes of a number of IDs, as reconstructed from serial
sections. The ladder-like structures indicate the position of the slit diaphragms, and the pins
indicate thelocation of coated regions of the epithelial cell membrane. Each ID,regardless of
its size, wasfoundto contact a region of coated membrane surface at some level. X 45,000.
TABLE I
Number ofImmune Deposits in Intact Kidney Tissue and in Isolated
GBMs at Various Time Points afterInjection ofAnti-gp3301gG
* n, Number of animals per group.
$ For each group IDs in 600-1000 Km of GBM were counted.
rats injected with anti-gp330 IgG were examined by electron microscopy, IDs
were seen to remain attached and coisolated with them at every time point.
When the number of IDs per 100 um GBM found in isolated GBMs was
compared with the number found in situ, there was no significant difference at
Time after
injection of
anti-gp330 IgG
n*
Number
deposits per
Intact tissue
of immune
100 Am GBM$
Isolated GBMs
15 min 4 16.7 15.2
30 min 2 21.3 18.6
1 h 4 12.6 14.4
2 h 2 17.7 ND
1 d 2 30.7 ND
3 d 4 90.8 84.7
8 d 2 66.5 ND118
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FIGURE 6. GBMs isolated from the kidneys of rats given rabbit anti-gp330 IgG 15 min
before killing, demonstrating that IDs remain attached and coisolate with them . The GBMs
were fixed, immobilized on poly-lysine-coated glass slides and incubated with goat anti-rabbit
IgG coupled to 10 nm gold (to localize the bound rabbit IgG), followed by monoclonal anti-
gp330 IgG and goat anti-mouse IgG coupled to 5 nm gold (to localize gp330). Five IDs
(arrows) are seen attached to the isolated GBM on the left, and three are seen on the right .
Note that most (-90%) of the gold particles are 5 nm in size, and relatively few (lowest arrow
in B) are 10 run, indicating that the antigen gp330 predominates in these early IDs . (US)
urinary space, (BM) glomerular basement membrane . x 85,000 .
any time point (Table I) . This indicates that (a) little or no loss of morphologically
recognizable IDs is brought about by the treatments to whichGBMs are exposed
during their isolation (hypotonic lysis, DNAse digestion and extraction in non-
ionic detergent [DOC]), and (b) the IDs are firmly bound to the GBM as early as
15 min after antibody injection .
Both gp330 and Anti-gp330 IgG Can Be Detected in IDs by Immunoelectron
Microscopy . Gp330 could be detected in IDs associated with isolated GBMs by
the immunogold procedure at all time points (Figs . 6 and 7) and by immunoper-
oxidase at later time points (Fig . 8) . Moreover, after double-immunolabeling for
gp330 (5 nm gold) and rabbit IgG (10 nm gold), both the antigen and the
antibody could be simultaneously demonstrated in the IDsattached to the isolated
GBM at all time points (Figs. 6 and 7) . The gold particles did not penetrate the
entire depth of most IDs when immunolabeling was done on aldehyde-fixed
GBMs . Counts of the two sizes of gold particles indicated that 5-nm gold
predominated at 15 min after injection (Fig. 6), whereas equal numbers of 5-nm
and -10 nm gold particles were observed after 3 d (Fig . 7) .
Gold particles were absent from the GBMs isolated from controls given
nonimmune IgG .
These findings indicate that (a) both the antigen and the antibody remain withduring theGBM isolation procedure and (h) initially the antigen/antibody
ratio is higher than at later time points.
and to Isolated GBMs.
￿
At 15 min and 1 h after
injection of the "'I-labeled IgG, 75 and 60%, respectively, of the counts were
lost from glomeruli during theGBM isolation procedure (Table 11) . By contrast,
after 3 d only-10% was lost, and >90% of the IgG remained bound to the
GBMs . In controls given gp330-depleted IgG, much less IgGremained associated
with the isolated glomeruli, and >80% of it was released during the GBM
preparation procedure at all time points .
When GBMs isolated from the 3-d experimental group were treated with 1-2
digested with heparinase or collagenase, very little radiolabeled
eased (Table 111). However, when the isolated GBMs were incubated
00mM diethylamine (pH >11) or I M acetic acid (pH c3.0), conditions that
are known to dissociate immune complexes (23-24), >65% of the radiolabeled
IgG was released .
Collectively, these findings together with the immunogold localization studies
suggest that at 15 min to 1 h after anti-gp330 IgG injection, much of the IgG
(60-75%) is loosely bound and is lost during GBM isolation, whereas after 3 d
irtually all of it is firmly bound to the IDs . Some of the firmly bound IgG (65%)
can be eluted by dissociating the antigen-antibody complexes, but a significant
amount (35%) cannot be eluted by any of the procedures tried .
Immune Deposits Contain Anti-gp330 IgGs with Acidic Isoelectric Points.
￿
When
KERJASCHKI ET AL .
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FIGURE 7 .
￿
Immunogold labeling ofGBMs isolated 3 d after anti-gp330 IgG injection and
processed as in Fig . &. At this time IDs are attached to theGBM viaa broad base, and the
antigen/antibody ratio is reduced: >50% of the particles present are 10 nm in size (indicating
rabbit IgG), and the remainder are 5 nm (indicating gp330 antigen). Occasionally, the two
sizes of gold particlesare found lined up in an alternating pattern (arrows). A, x 110,000 ; B,
x95,000 ;C andD, x 120,000 .120 PASSIVE HEYMANN NEPHRITIS
FiGuRF 8,
￿
Double-immunolabeling for gp330 and rabbit IgG of IDs attached to isolated
GBMW at I h {t, 3 d (B) or 8 d {C} . Unfixed, GBMs were embedded in agaroseanddoubly
incubated in monoclonal anti-gp330 detected by indirect immunoperoxidase (to label gp330)
and in 5 mn gold-protein A conjugate (to label bound anti-gp330) . The presence of
IgG is demonstrated by the presence of gold particles in all IDs . gp330 is not detect
the peroxidase technique at I h (probably because the DAB reaction product i
diffusion), but it is readily detected in the more compact IDs seen at 3-8 d . A
substructure is visible in the less compact IDs seen at I h (arrows) . A, x 32,000 ; B a
X 85,000 .
the IgGs that bound to glomeruli from rats given rabbit anti-gp330 3 d earlier
were eluted and used for immunoprecipitation, only gp330 was precipitat
(data not shown). Similar results were obtained previously (3) with IgGs
from glomeruli of rats with active HN induced by immunization with gp330. To
find out whether the bound anti-gp330 IgGs belong to anionic or cationic
subclasses, we compared the isoelectric points of the eluted IgGs with those of
the injected native (nonradiolabeled) and radiolabeled anti-gp330 IgG. The
latter showed a broad range of isoelectric points from pi 5.0 to 8.5 (Fig . 9,
and B). The pattern was identical with both native Ig
￿
(A)
gp330, indicating that the iodination of anti-gp330 did not substanti
h lectric points . When the isoelectric points of the IgGs cit
of either I -h and 3-d injected animals were determined, two
major subspecies were observed with acidic isoelectric points of -5.0 and 6.1TABLE II
Bindingof '257-labeled Rabbit Anti-gp330 IgG to Isolated Glomeruli and GBMs
Antibody
injected
Four rats per experimental groupwere injected with 3 mg rabbit anti-gp330 IgGsupplemented with
2 mg '251-labeled, rabbit anti-gp330 IgG (sp act, 250,000 cpm/kg). Seven rats were injected with 5
mg of control IgG (sp act, 120,000 cpm/;ig). Animals were killed at the time points indicated, the
kidneys from each group were pooled, their glomeruli were isolated, and their radioactivity was
determined. GBMs were subsequently purified from each glomerular fraction, and the amount of
radioactive IgG remaining in the GBM fractions wasdetermined.
KERJASCHKI ET AL.
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Anti-gp330 IgG
Control IgG
TABLE III
Extraction of ` 251-labeledIgGBound to GBMFractions
Discussion
* GBM fractions of the 3-d groups used in Table I were divided into subgroups (5,000 cpm each)
and treated with the agents listed as detailed in MaterialsandMethods.
$GBM fractions of control groups were similarly divided into subgroups (^700 cpm each).
(Fig. 9C). It can be concluded that in this disease model charge interaction is
not the predominant factor in determining which IgGs cross the GBM and are
incorporated into IDs, because the bound species are largely anionic, rather than
cationic IgGs.
In this paper we have studied the initial events that occur in the formation of
IDs in passive HN. Several new findings have emerged as follows: (a) clathrin-
coated pits located at the bases ofthe foot processes represent the site where the
circulating anti-gp330 IgG and the resident gp330 antigen initially meet; (b) IDs
Antibody
injected Extraction procedure
Radioactivity
Totalbound Released
Amount
extracted
cpm %
Anti-gp330 IgG* NaCl (1 M) 4,206 402 8.8
NaCl (2 M) 4,524 360 7.9
Heparinase 5,103 538 10.5
Collagenase 3,492 438 12.5
Diethylamine (100 mM) 5,088 3,399 66.8
Acetic acid (1 M) 5,200 3,635 69.9
Control IgG$ NaCl (1 M) 668 334 50
NaCl (2 M) 698 348 50
Heparinase 684 320 46
Collagenase 683 351 51
Diethylamine (100 mM) 657 320 49
Acetic acid (1 M) ND ND ND
Time after
injection
Glomerular
Label bound
fraction
IgGbound
Isolated
Label bound
GBMs
IgGbound
cpm kg cpm Wg
15 min 3,077 12.0 753 3.0
1 h 11,915 46.6 3,445 13.8
3 d 185,371 741.0 153,955 615.0
15 min 832 3.3 195 0.7
1 h 1,716 6.9 410 1.6
3 d 2,208 8.8 210 0.8122
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FIGURE 9 .
￿
Isoelectric focusing of rabbit anti-gp330 IgG . (A) Coo-
massie blue-stained, protein A-purified, rabbit anti-gp330 IfG. (B)
Autoradiogram ofthe same fraction as inAafter labeling with "I . (C)
Autoradiogram of IgG eluted from isolated glomeruli of rats killed 3
d after injection of the fraction shown in B and purified on protein A-
Sepharose . The range of isoelectric points of native (A) and radiola-
beled (B) IgG are very similar, whereas the rabbit IgG eluted from
glomeruli of injected rats (C) is composed mainly of IgGs with acidic
pIs (5.0-6.1). The line in the region of pI 7 in C is where the sample
was loaded onto the gel .
FIGURE 10 .
￿
Schematicdrawingof the early events in the formation of an ID in passive HN .
(A) Circulating anti-gp330 IgG (Y) penetrates the GBMandapproaches gp330 (9), a resident
membrane glycoprotein of clathrin-coated pits located at the base of the epithelial foot
processes . (B) Anti-gp330 IgG binds to its antigen, gp330, in the coated pits forming an
immune complex . (C) The initial immune complex becomes attached to the GBM as early as
15 min after injection of antibody, and is shed but remains in contact with a coated pit . (D)
The ID grows in size by repeated cycles of in situ immune complex formation and shedding
into the lamina rara externa until it eventually encroaches on the area of the slit diaphragm .
The same result could be obtained if the ID is fixed to one site on the GBM and the foot
process subsequently moves over the ID until positioned under the slit diaphragm . The
continuedgrowth of the IDs appears to require the de novo synthesis by the podocytes of new
molecules of gp330 which, like other membrane glycoproteins, are assumed to be delivered
via vesicles (ve) that eventually fuse with the cell membrane at the base of the foot processes .
become firmly fixed to the GBM by 15 min after antibody injection ; (c) IDs
remain associated with coated pits at the base of the foot processes up to 8 d
after IgG injection ; and (d) both the antigen (gp 330) and the antibody (anti-
gp330) are present throughout the IDs at all time points .
The results of our experiments have provided new information, summarized
in Fig . 10, that allow us to reconstruct the early events that occur in theKERJASCHKI ET AL.
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generation of IN in passive HN as follows: Within minutes after its administra-
tion, anti-gp330 IgG penetrates the GBMand binds toitsantigen, gp330, located
in coated pits at the base of the foot processes. Although gp330 is a resident
membrane protein of coated pits found on the epithelial cell body and on the
sides and the base of the foot processes, the antibody has access only to those
coated pits located on the soles ofthe podocyte's feet, because immunolabeling
reveals that binding of IgG occurs exclusively in this site. Immediately (within
15 min) after binding, theimmune complexes form morphologically recognizable
IDs that become so firmly attached to the GBM that they coisolate with it. This
firm attachment must involve strong, probably covalent, interactions between
the GBM and the antigen or antibody because it resists high salt, detergent,
collagenase, and heparinase treatments. It is disrupted only by reagents that
dissociate antigen-antibody complexes. With increasing time (I h to 8 d) after
IgG injection, the IDs grow in size as a result of the continued penetration of
IgG across the GBM, and they are eventually shed into the lamina rara externa
(4, 5, 25, 26). It is not clear exactly when shedding occurs in relationship to
attachment and growth ofthe IDs, but that shedding does occur is suggested by
experiments on cultured glomerular epithelial cells (25, 26) and by the fact that
both antigen and antibody can be demonstrated in the IN at some distance from
the epithelial cell membrane, i.e., at a distance greater than the ectodomain of
the gp330 molecule would be expected to protrude from the surface of the
epithelial cell membrane. The simplest explanation for the gradual increase in
size of the IDs is that they grow by repeated IgG binding and shedding of the
resultant immunecomplexes. Bindingofcirculating IgG directlytofreeantigenic
sites on the shed antigen and deposition ofcomponents ofcomplement (C3 and
C5 to C9) (27-29) may also contribute to the process. For the continued growth
of the IDs to take place undoubtedly requires the synthesis of new gp330
molecules and their insertion into the coated pitsat the baseofthe foot processes.
The fact that there is a lag period after the initial injection of IgG before the
number of IN increases (from -17-90/jm GBM), together with the fact that a
similar lag period was shown to occur before gp330 reappears on the surface of
cultured epithelial cells after antibody-induced shedding of gp330-containing
immune complexes (25), also suggests that de novo synthesis ofgp330 is required.
As the IDs grow in size and surface area they gradually encroach on the areas
under the slit diaphragms, and their relationship to coated pits becomes less
obvious. However, asdetermined by serial sectioning, each ID maintains contact
with a coated pit on some part of its surface.
The question immediately arises as to how the IDs can maintain contact with
a coated pit in the face ofcontinual antigen shedding. This would be possible if,
as suggested by the experiments ofSeiler et al. (30), the epithelial cell membrane
at the base of the foot processes or the entire foot process can move along the
outer surface ofthe GBM, because as new gp330 molecules appear in coated pits
along the basal epithelial membrane the antigen would likely become fixed to
the IDs by binding to free sites on the deposited IgG.
The finding that the IDs become rapidly fixed to the GBM by interactions
that resist hypotonic lysis and detergent extraction during GBM isolation may
explain why the epithelial cells are unable to remove and dispose of the IDs.124
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Other filtration residues that accumulate in the lamina rara externa, such as
native (anionic) ferritin (31), neutral dextrans (32), and poly-lysine-heparin
complexes (33), are efficiently incorporated into the epithelium by endocytosis
and disposed of in lysosomes. The fact that proteins became rapidly attached to
the GBM may also explain why some exogenous proteins, especially those that
are cationic in nature (34) and bind to anionic sites in the GBM, persist in
glomeruli and serve as implanted antigens.
Several treatments were carried out on isolated GBMs in an attempt to gain
insights into the nature of the interaction between gp330 and/or anti-gp330 and
the GBM, but none released the bound 's5I-labeled IgG except those treatments
(high or low pH) that disrupt antigen-antibody complexes. Although the mech-
anism(s) by which the IDs become fixed to the GBM remains unknown, several
possibilities can be ruled out or considered unlikely, e .g., that it occurs by charge
or hydrophobic interactions or by crosslinking to collagen or heparan sulfate,
because treatment with high salt or detergent or with collagenase or heparinase
failed to release bound IgG . In all likelihood the attachment is covalent, but the
nature of the binding remains to be established. The GBM itself is known to be
oflow solubility and to be stabilized by intra- and intermolecular disulfide bridges
and nonreducible bonds (35).
Several requirements for the persistence of IDs in passive HN have been
established as a result of previous studies. To begin with, the presence of anti-
gp330 is required. Although antibodies to other glomerular epithelial cell-surface
components such as a 90-94-kD glycoprotein (11, 36) and podocalyxin (21, our
unpublished results) bind to glomeruli after intravenous injection, the binding
does not lead to the formation of persisting IDs. In addition, it is known that
precipitating, multivalent antibodies are required because nonprecipitating an-
tibodies (37) and mixtures of mAbs antibodies (38) were ineffective in promoting
ID formation. Moreover, only immune complexes in which the antigen and
antibody can condense and rearrange into larger latticed IDs persist in glomeruli
and become electron-dense deposits (39). It is the inability to undergo this type
of rearrangement that probably prevents ID formation in anti-GBM-type glo-
merulonephritis caused by binding of antibodies to antigens such as laminin (40)
and heparan-sulfate proteoglycans (41) that are firmly fixed in the GBM. In the
case of gp330-anti-gp330 complexes, shedding is probably a necessary prereq-
uisite for condensation and rearrangement of immune complexes. Complement
does not seem to be required for ID formation as IN form in complement-
depleted animals (27); however, complement is required for proteinuria to occur
(29). Although there are circumstances where positively charged antibodies have
been shown to bind to the GBM more readily than negatively charged antibodies
(42, 43), our results, as well as those of Adler et al . (44), indicate that in this
disease model, positively charged antibodies are not involved because the bound
IgGs consisted of anionic species with acidic isoelectric points (5.0 and 6 .1).
The results of our experiments raise several questions that must be answered
for the molecular events leading to the formation of IDs to be fully understood
and to devise appropriate strategies for preventing ID formation or their stabi-
lization once they have formed. The most pressing is to define the nature of the
interactions between gp330 and the GBM. In addition, one would like to be ableKERJASCHKI ET AL.
￿
125
to explain why immune complexes formed in situ with gp330 are stable and
grow, whereas those induced by antibodies against two other resident membrane
glycoproteins of glomerular epithelial cells, i.e., podocalyxin (our unpublished
data) and a 94-kD glycoprotein (11, 36), are only transient. Since both podoca-
lyxin and the 94-kD glycoprotein are present at the surface of the glomerular
endothelium as well as the epithelium, it is likely that these antibodies may be
removed from the circulation before reaching the epithelium by "antibody
modulation," that is, by binding of the antibody to the endothelium, followed by
capping and internalization of the resultant immune complexes or their shedding
into the circulation (26, 45). gp330 differs from the other two antigens mentioned
in that it is exclusively an epithelial antigen that is not accessible to circulating
antibodies in any organ other than the kidney, and anti-gp330 IgG persists
several hours to days in the circulation (41). Finally, one would like to know to
what extent formation of IDs is specific for gp330 and related to unique features
of its molecular structure or functions (e.g., in endocytosis).
Summary
The nephritogenic antigen of Heymann's nephritis (HN), gp330, was previ-
ously demonstrated (4-9) to be a resident glycoprotein of coated pits in the
glomerular and proximal tubule epithelium of rats, and anti-gp330 IgG given
intravenously was found to form IDs in glomeruli (passive HN). The purpose of
this study was to investigate the detailed events that occur in the formation of
IDs in passive HN . HN was induced by the injection of either 125I-labeled or
unlabeled anti-gp330 IgG. At various times after injection (15 min to 8 d) the
kidneys of some of the injected rats were fixed by perfusion, and the distribution
of the rabbit IgG was determined by immunofluorescence and by immunoelec-
tron microscopy. Glomeruli were isolated from the kidneys of injected rats and
used for isolation of GBM fractions or for elution of the bound IgG.
At 15 min to 1 h after injection, the rabbit IgG was localized by immunocy-
tochemistry exclusively in coated pits along the podocyte plasmalemma facing
the GBM. By 1-8 d, anti-gp330 IgG was detected in larger electron-dense IDs
often located under the slit diaphragms. Serial sectioning revealed that each of
the IDs maintained contact with a coated pit at some level. When GBMs isolated
from rats given radiolabeled anti-gp330 IgG were examined by electron micros-
copy, the IDs were found to remain attached to the GBMs as early as 15 min
after injection and coisolated with them at all time points. By double-immuno-
labeling of the isolated GBMs with two sizes of gold particles, both the antigen
(gp330) and the anti-gp330 IgG could be demonstrated in IDs at all time points.
When the amount of radiolabeled anti-gp330 bound to GBM fractions was
compared with that of isolated glomeruli, it was found that 20% of the radiolabel
remained bound to the purified GBMs at 15 min after injection, and 90% at 3
d. The bound IgG was released only by treatments that disrupt antibody-antigen
complexes (high and low pH), but not by the other treatments we tried (detergent,
high salt, heparinase, or collagenase digestion).
When the IgG bound to glomeruli was eluted with acid citrate buffer 3 d after
injection, it was found to specifically immunoprecipitate only gp330 from deter-12 6
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gent-solubilized 121I-labeled kidney microvillar vesicles. By isoelectric focusing
the eluate was found to be enriched in IgGs with acidic isoelectric points.
These results confirm and extend previous data (4-9) indicating that coated
pits at the base of the foot processes are the sites where resident gp330 and
circulating anti-gp330 meet to form the initial immune complexes. They further
demonstrate that the IDs remain in contact with coated pits up to 8 d after
injection. A major new finding was that, as early as 15 min after injection of
anti-gp330 IgG, morphologically recognizable IDs become firmly attached to the
GBM by unknown, probably covalent, interactions.
Receivedfor publication 29 December 1986 and in revisedform 26 March 1987.
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